To develop a new evidence-based diagnosis,treatment guideline for rheumatoid arthritis (RA) in China.A multidisciplinary guideline development group was established.The grading of recommendations assessment,development and evaluation (GRADE) system was used to rate the quality of evidence and the strength of recommendations.Recommendations were derived from evidence body,the balance of benefits and harmsand patient's values and preferences.The guideline development group developed 10 recommendations for the diagnosis and treatment of RA.The guideline covered the classification criteria,disease activity monitoring and assessing,antirheumatic drugs (DMARDs) and glucocorticoids with treat-to-target approach of RA.This rheumatoid arthritis guideline was intended to serve as a tool for clinicians and patients for best decisions-making in China.

Child ; Consensus ; Flow Cytometry ; methods ; Humans ; Lymphocyte Count ; Lymphocyte Subsets ; Practice Guidelines as Topic ; T-Lymphocyte Subsets

In order to standardize the application of imaging techniques in the clinical diagnosis and treatment of patients with Takayasu arteritis in China,the protocol for development of the guidelines for the imaging diagnosis and treatment of Takayasu arteritis was written by Zhongshan Hospital of Fudan University,the Rheumatology Committee of Chinese Medical Association,China Primary Health Care Foundation,and the Evidence-Based Medicine Center of Fudan University.The guideline working group will standardize the development of guidelines based on the existing imaging literature evidence of Takayasu arteritis and with reference to the WHO Guideline Development Manual.This protocol mainly introduced the significance of guideline formulation,the formation of working group,the selection of clinical problems,evidence retrieval and evaluation,the formation and publication of guidelines and other processes.